Secondary Hyperparathyroidism

Pro-Inflammatory Diet Associated With Elevated Parathyroid Hormone Levels

Publish Date July 26, 2021

In a cross-sectional study, hyperparathyroidism occurred more frequently in adults with a diet of high vs low inflammatory potential.

Etelcalcetide Shows Efficacy in Clinical Practice

Publish Date July 23, 2021

Patients on hemodialysis who have secondary hyperparathyroidism experienced a 40% reduction in PTH levels over 12 months of etelcalcetide treatment, investigators reported.

Anemia, SHPT Are Possible Cardiovascular Risk Factors in Kidney Transplant Recipients

Publish Date July 22, 2021

In a small study, approximately a third of kidney transplant recipients had anemia and half had persistent secondary hyperparathyroidism.

High iPTH Linked With Cardiovascular Outcomes in Diabetic Kidney Disease

Publish Date July 21, 2021

Study findings indicate a correlation between iPTH and vascular calcification in patients with diabetic kidney disease.

SHPT Linked With Weight Loss, Death

Publish Date June 21, 2021

Weight loss partly accounted for the association between high parathyroid hormone levels and mortality among patients on hemodialysis.

Panel Reaches Broad Clinical Consensus on SHPT Management

Publish Date June 18, 2021

An expert panel of US nephrologists and other health care providers unanimously agreed that secondary hyperparathyroidism treatment is often started too late in patients with chronic kidney disease.

SHPT, Hyperphosphatemia Independently Linked With CKD Progression

Publish Date June 15, 2021

Investigators ruled out hyperphosphatemia and SHPT as confounders in each other’s association with CKD outcomes.

Study: Etelcalcetide Can Be Used Safely in Diabetic Nephropathy

Publish Date June 10, 2021

Etelcalcetide use in patients with diabetic nephropathy might protect against development of adynamic bone disease, according to investigators.

Non-Calcium Phosphate Binder May Not Further Reduce Cardiovascular Events

Publish Date June 3, 2021

Trial investigated lanthanum carbonate, which has been used worldwide to treat hyperphosphatemia and has been reported to delay vascular calcification.

Calciphylaxis Prevention and Treatment Strategies

Publish Date June 2, 2021

Calciphylaxis treatment should include a multimodal approach with a focus on supportive care, infection prevention, pain management, and wound healing.